Camodix

**Camodix** is an oral dispersible fixed-dose antibacterial product developed and marketed by Sam-A Pharm. It combines **amoxicillin**, a bactericidal aminopenicillin that inhibits bacterial penicillin-binding proteins and cell-wall peptidoglycan synthesis, with **clavulanate potassium**, a beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation. The Sam-A Pharm product listing identifies the dispersible-tablet formulation as a 4:1 amoxicillin-to-clavulanate potassium combination for respiratory infections, including pharyngitis, tonsillitis, sinusitis, and pneumonia. ([samapharm.co.kr](https://www.samapharm.co.kr/eng/Product/goodsList.asp?s_cate=32&s_catetop=28))

Brand names

Camodix

Other names

co-amoxiclavamoxicillin-clavulanateamoxicillin and clavulanate potassium